Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eduard Cheptanaru"'
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 74, Iss 3, Pp 242-246 (2022)
Anomalia Ebstein este o malformație cardiacă congenitală a valvei tricuspide și a ventriculului drept. Corecția chirurgicală a anomaliei Ebstein îmbunătățește clasa funcțională și toleranța la efort, elimină șuntarea intracardiacă d
Externí odkaz:
https://doaj.org/article/2c9bcb4d0715486582b199b3000d87cc
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 74, Iss 3, Pp 230-234 (2022)
Tetralogia Fallot (TF) prezintă o prevalenţă mondială în mediu de 1 la 3000 nou-născuţi vii, astfel reprezentînd cea mai frecventă malformație cardiacă cianogenă. Tipul de corecție radicală abordat depinde de severitatea stenozei tractu
Externí odkaz:
https://doaj.org/article/2282c78374244449aca1352b3b912c56
Publikováno v:
Bulletin of the Academy of Sciences of Moldova. Medical Sciences. 74:242-246
Ebstein anomaly is a congenital heart malformation of the tricuspid valve and right ventricle. Surgical correction of Ebstein’s anomaly improves functional class and exercise tolerance, eliminates intracardiac right-to-left shunting (if present), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::252957633ffd84d5f8dc8d0ecb662082
https://doi.org/10.52692/1857-0011.2022.3-74.48
https://doi.org/10.52692/1857-0011.2022.3-74.48
Publikováno v:
Bulletin of the Academy of Sciences of Moldova. Medical Sciences. 74:230-234
Tetralogy of Fallot (TF) has a worldwide prevalence of approximately 1 in 3000 live newborns, thus representing the most common cyanogenic cardiac malformation. The type of radical correction approached depends on the severity of right ventricular ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b7386f41a5b06f17b412970ef7709bb
https://doi.org/10.52692/1857-0011.2022.3-74.46
https://doi.org/10.52692/1857-0011.2022.3-74.46
Autor:
Dmitry Bobylev, Alexander Horke, Murat Avsar, Tomislav Cvitkovic, Dietmar Boethig, Mark Hazekamp, Bart Meyns, Filip Rega, Hitendu Dave, Martin Schmiady, Anatol Ciubotaru, Eduard Cheptanaru, Vladimiro Vida, Massimo Padalino, Victor Tsang, Ramadan Jashari, Günther Laufer, Martin Andreas, Alexandra Andreeva, Igor Tudorache, Serghei Cebotari, Axel Haverich, Samir Sarikouch
Publikováno v:
Cell and Tissue Banking.
For decades, bovine jugular vein conduits (BJV) and classic cryopreserved homografts have been the two most widely used options for pulmonary valve replacement (PVR) in congenital heart disease. More recently, decellularized pulmonary homografts (DPH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19697264470bfb7047790c64671fc1e3
https://doi.org/10.1007/s10561-023-10082-4
https://doi.org/10.1007/s10561-023-10082-4
Autor:
Dmitry Bobylev, Alexander Horke, Dietmar Boethig, Mark Hazekamp, Bart Meyns, Filip Rega, Hitendu Dave, Martin Schmiady, Anatol Ciubotaru, Eduard Cheptanaru, Vladimiro Vida, Massimo Padalino, Victor Tsang, Ramadan Jashari, Günther Laufer, Martin Andreas, Alexandra Andreeva, Igor Tudorache, Serghei Cebotari, Axel Haverich, Samir Sarikouch
Publikováno v:
European Journal of Cardio-Thoracic Surgery, 62(5). OXFORD UNIV PRESS INC
OBJECTIVES Early results from the prospective ESPOIR Trial have indicated excellent results for pulmonary valve replacement using decellularized pulmonary homografts (DPH). METHODS A 5-year analysis of ESPOIR Trial patients was performed to provide a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49710e93cc0774b1d5667d68b48f2b4
https://lirias.kuleuven.be/handle/20.500.12942/698444
https://lirias.kuleuven.be/handle/20.500.12942/698444
Autor:
Liviu Maniuc, Thomas Breymann, Anatol Cazacu, Axel Haverich, Dietmar Boethig, Artur Lichtenberg, Oleg Repin, Anatol Ciubotaru, Igor Tudorache, Samir Sarikouch, Eduard Cheptanaru, A. Goerler, Serghei Cebotari, Sergiu Barnaciuc, Oxana Maliga
Publikováno v:
Circulation. 124
Background— Degeneration of xenografts or homografts is a major cause for reoperation in young patients after pulmonary valve replacement. We present the early results of fresh decellularized pulmonary homografts (DPH) implantation compared with gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::676c7083baa9391152e4ee3c8edbe340
https://pubmed.ncbi.nlm.nih.gov/21911800
https://pubmed.ncbi.nlm.nih.gov/21911800
Autor:
Samir Sarikouch, Dmitry Bobylev, Karolina Theodoridis, Serghei Cebotari, Mechthild Westhoff-Bleck, Harald Bertram, Igor Tudorache, Eduard Cheptanaru, Philipp Beerbaum, Dietmar Boethig, Axel Haverich, Alexander Horke, Anatol Ciubotaru, Thomas Breymann
Publikováno v:
European Journal of Cardio-Thoracic Surgery
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
OBJECTIVES The choice of valve prosthesis for aortic valve replacement (AVR) in young patients is challenging. Decellularized pulmonary homografts (DPHs) have shown excellent results in pulmonary position. Here, we report our early clinical results u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870169eb05e289881f54823448f842ae